France W Fung1,2, Jiaxin Fan3, Darshana S Parikh1, Lisa Vala4, Maureen Donnelly4, Marin Jacobwitz1, Alexis A Topjian5,6, Rui Xiao3, Nicholas S Abend1,2,3,4,6. 1. Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 2. Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 3. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 4. Department of Neurodiagnostics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 5. Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and. 6. Department of Anesthesia & Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Abstract
PURPOSE: Continuous EEG monitoring (CEEG) to identify electrographic seizures (ES) in critically ill children is resource intense. Targeted strategies could enhance implementation feasibility. We aimed to validate previously published findings regarding the optimal CEEG duration to identify ES in critically ill children. METHODS: This was a prospective observational study of 1,399 consecutive critically ill children with encephalopathy. We validated the findings of a multistate survival model generated in a published cohort (N = 719) in a new validation cohort (N = 680). The model aimed to determine the CEEG duration at which there was <15%, <10%, <5%, or <2% risk of experiencing ES if CEEG were continued longer. The model included baseline clinical risk factors and emergent EEG risk factors. RESULTS: A model aiming to determine the CEEG duration at which a patient had <10% risk of ES if CEEG were continued longer showed similar performance in the generation and validation cohorts. Patients without emergent EEG risk factors would undergo 7 hours of CEEG in both cohorts, whereas patients with emergent EEG risk factors would undergo 44 and 36 hours of CEEG in the generation and validation cohorts, respectively. The <10% risk of ES model would yield a 28% or 64% reduction in CEEG hours compared with guidelines recommending CEEG for 24 or 48 hours, respectively. CONCLUSIONS: This model enables implementation of a data-driven strategy that targets CEEG duration based on readily available clinical and EEG variables. This approach could identify most critically ill children experiencing ES while optimizing CEEG use.
PURPOSE: Continuous EEG monitoring (CEEG) to identify electrographic seizures (ES) in critically ill children is resource intense. Targeted strategies could enhance implementation feasibility. We aimed to validate previously published findings regarding the optimal CEEG duration to identify ES in critically ill children. METHODS: This was a prospective observational study of 1,399 consecutive critically ill children with encephalopathy. We validated the findings of a multistate survival model generated in a published cohort (N = 719) in a new validation cohort (N = 680). The model aimed to determine the CEEG duration at which there was <15%, <10%, <5%, or <2% risk of experiencing ES if CEEG were continued longer. The model included baseline clinical risk factors and emergent EEG risk factors. RESULTS: A model aiming to determine the CEEG duration at which a patient had <10% risk of ES if CEEG were continued longer showed similar performance in the generation and validation cohorts. Patients without emergent EEG risk factors would undergo 7 hours of CEEG in both cohorts, whereas patients with emergent EEG risk factors would undergo 44 and 36 hours of CEEG in the generation and validation cohorts, respectively. The <10% risk of ES model would yield a 28% or 64% reduction in CEEG hours compared with guidelines recommending CEEG for 24 or 48 hours, respectively. CONCLUSIONS: This model enables implementation of a data-driven strategy that targets CEEG duration based on readily available clinical and EEG variables. This approach could identify most critically ill children experiencing ES while optimizing CEEG use.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Katherine L Wagenman; Taylor P Blake; Sarah M Sanchez; Maria T Schultheis; Jerilynn Radcliffe; Robert A Berg; Dennis J Dlugos; Alexis A Topjian; Nicholas S Abend Journal: Neurology Date: 2014-01-02 Impact factor: 9.910
Authors: Nicholas S Abend; Ana Gutierrez-Colina; Huaqing Zhao; Rong Guo; Eric Marsh; Robert R Clancy; Dennis J Dlugos Journal: J Clin Neurophysiol Date: 2011-02 Impact factor: 2.177
Authors: Juan A Piantino; Mark S Wainwright; Michele Grimason; Craig M Smith; Elora Hussain; Dan Byron; Anthony Chin; Carl Backer; Marleta Reynolds; Joshua Goldstein Journal: Pediatr Crit Care Med Date: 2013-07 Impact factor: 3.624
Authors: Hansel M Greiner; Katherine Holland; James L Leach; Paul S Horn; Andrew D Hershey; Douglas F Rose Journal: Pediatrics Date: 2012-02-13 Impact factor: 7.124
Authors: Aaron F Struck; Gamaleldin Osman; Nishi Rampal; Siddhartha Biswal; Benjamin Legros; Lawrence J Hirsch; M Brandon Westover; Nicolas Gaspard Journal: Ann Neurol Date: 2017-07-19 Impact factor: 10.422
Authors: Eric T Payne; Xiu Yan Zhao; Helena Frndova; Kristin McBain; Rohit Sharma; James S Hutchison; Cecil D Hahn Journal: Brain Date: 2014-03-04 Impact factor: 13.501
Authors: Daniel E Leisman; Michael O Harhay; David J Lederer; Michael Abramson; Alex A Adjei; Jan Bakker; Zuhair K Ballas; Esther Barreiro; Scott C Bell; Rinaldo Bellomo; Jonathan A Bernstein; Richard D Branson; Vito Brusasco; James D Chalmers; Sudhansu Chokroverty; Giuseppe Citerio; Nancy A Collop; Colin R Cooke; James D Crapo; Gavin Donaldson; Dominic A Fitzgerald; Emma Grainger; Lauren Hale; Felix J Herth; Patrick M Kochanek; Guy Marks; J Randall Moorman; David E Ost; Michael Schatz; Aziz Sheikh; Alan R Smyth; Iain Stewart; Paul W Stewart; Erik R Swenson; Ronald Szymusiak; Jean-Louis Teboul; Jean-Louis Vincent; Jadwiga A Wedzicha; David M Maslove Journal: Crit Care Med Date: 2020-05 Impact factor: 7.598